BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27173185)

  • 1. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
    Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Tajiri R; Inokuchi M; Sawada-Kitamura S; Kawashima H; Nakamura R; Oyama T; Dobashi Y; Ooi A
    Pathol Int; 2014 May; 64(5):231-6. PubMed ID: 24888777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
    Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
    Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
    Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
    J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
    Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
    Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
    Narendra S; Jenkins SM; Khoor A; Nassar A
    Ann Diagn Pathol; 2015 Apr; 19(2):64-9. PubMed ID: 25682191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evolutionary patterns in breast cancer.
    Shackney SE; Silverman JF
    Adv Anat Pathol; 2003 Sep; 10(5):278-90. PubMed ID: 12973049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
    Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
    Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
    Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
    Park CK; Jung WH; Koo JS
    Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
    Ciriello G; Gatza ML; Beck AH; Wilkerson MD; Rhie SK; Pastore A; Zhang H; McLellan M; Yau C; Kandoth C; Bowlby R; Shen H; Hayat S; Fieldhouse R; Lester SC; Tse GM; Factor RE; Collins LC; Allison KH; Chen YY; Jensen K; Johnson NB; Oesterreich S; Mills GB; Cherniack AD; Robertson G; Benz C; Sander C; Laird PW; Hoadley KA; King TA; ; Perou CM
    Cell; 2015 Oct; 163(2):506-19. PubMed ID: 26451490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma.
    Cao L; Basudan A; Sikora MJ; Bahreini A; Tasdemir N; Levine KM; Jankowitz RC; McAuliffe PF; Dabbs D; Haupt S; Haupt Y; Lucas PC; Lee AV; Oesterreich S; Atkinson JM
    Cancer Lett; 2019 Oct; 461():21-30. PubMed ID: 31229512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
    de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
    Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation biomarkers for pleomorphic lobular breast cancer - a short report.
    Moelans CB; Vlug EJ; Ercan C; Bult P; Buerger H; Cserni G; van Diest PJ; Derksen PW
    Cell Oncol (Dordr); 2015 Oct; 38(5):397-405. PubMed ID: 26392358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
    Cha YJ; Kim HM; Koo JS
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.